Market Overview

Merck Unchanged

Related MRK
Merck Has An Upcoming PDUFA Date For Bezlotoxumab
Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments
Here's How Lilly And Merck Are Faring In The Cancer Drug Wars: Earnings Out Next Week (Seeking Alpha)

Merck (NYSE: MRK) shares are unchanged at $56.69 in Wednesday's trading. After breaching Tuesday's low ($56.57) off the open, reaching $56.26, the issue has rebounded to $56.93. The major resistance for MRK stands between $57.39 and $57.65, which represents the highs in the last five trading sessions.

Posted-In: Technicals Intraday Update Trading Ideas


Related Articles (MRK)

View Comments and Join the Discussion!